On the public citation graph

Non‐invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE

0 signed · 269 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 63 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-18): 10.1210/jc.2014-2739 (notice 2015-05-01).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2014.11494openalex-snapshot
Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012
inferredcites →https://doi.org/10.1002/dmrr.1291openalex-snapshot
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis
inferredcites →https://doi.org/10.1002/hep.23425openalex-snapshot
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
inferredcites →https://doi.org/10.1002/hep.25731openalex-snapshot
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.26072openalex-snapshot
Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?
inferredcites →https://doi.org/10.1002/hep.26455openalex-snapshot
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
inferredcites →https://doi.org/10.1002/hep.27014openalex-snapshot
Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly
inferredcites →https://doi.org/10.1002/hep.27362openalex-snapshot
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
inferredcites →https://doi.org/10.1002/hep.27647openalex-snapshot
Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)
inferredcites →https://doi.org/10.1002/hep.510300604openalex-snapshot
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/jmri.22701openalex-snapshot
Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms
inferredcites →https://doi.org/10.1002/jmri.24284openalex-snapshot
Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects
inferredcites →https://doi.org/10.1002/jmri.24321openalex-snapshot
Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1007/s00330-010-1905-5openalex-snapshot
The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis
inferredcites →https://doi.org/10.1016/j.cgh.2007.06.012openalex-snapshot
Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
inferredcites →https://doi.org/10.1016/j.cgh.2014.04.014openalex-snapshot
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
inferredcites →https://doi.org/10.1016/j.cgh.2014.11.027openalex-snapshot
Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique
inferredcites →https://doi.org/10.1016/j.cld.2009.07.009openalex-snapshot
Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2004.09.012openalex-snapshot
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
inferredcites →https://doi.org/10.1016/j.jhep.2013.04.027openalex-snapshot
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
inferredcites →https://doi.org/10.1016/j.jhep.2013.12.018openalex-snapshot
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations
inferredcites →https://doi.org/10.1016/s0016-5085(99)70506-8openalex-snapshot
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
inferredcites →https://doi.org/10.1016/s0140-6736(07)61602-xopenalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
inferredcites →https://doi.org/10.1016/s1542-3565(04)00014-xopenalex-snapshot
Nonalcoholic fatty liver disease in patients with type 2 diabetes
inferredcites →https://doi.org/10.1038/ajg.2010.18openalex-snapshot
Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
inferredcites →https://doi.org/10.1038/ajg.2012.331openalex-snapshot
Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1038/ajg.2014.134openalex-snapshot
Nonalcoholic Fatty Liver Disease is Underrecognized in the Primary Care Setting
inferredcites →https://doi.org/10.1038/nrgastro.2013.175openalex-snapshot
Noninvasive evaluation of NAFLD
inferredcites →https://doi.org/10.1053/j.gastro.2010.09.038openalex-snapshot
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
inferredcites →https://doi.org/10.1093/aje/kws448openalex-snapshot
Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
inferredcites →https://doi.org/10.1093/qjmed/hcr233openalex-snapshot
Prevalence and markers of advanced liver disease in type 2 diabetes
inferredcites →https://doi.org/10.1097/mcg.0000000000000075openalex-snapshot
Low Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk
inferredcites →https://doi.org/10.1111/apt.12084openalex-snapshot
Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/apt.12569openalex-snapshot
Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments
inferredcites →https://doi.org/10.1111/apt.12963openalex-snapshot
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/apt.13196openalex-snapshot
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study
inferredcites →https://doi.org/10.1111/apt.13292openalex-snapshot
Novel association between serum pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1360-0443.1993.tb02093.xopenalex-snapshot
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
inferredcites →https://doi.org/10.1111/j.1365-2036.2012.05121.xopenalex-snapshot
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD
inferredcites →https://doi.org/10.1111/j.1440-1746.2004.03312.xopenalex-snapshot
Non‐alcoholic steatohepatitis in type 2 diabetes mellitus
inferredcites →https://doi.org/10.1111/j.1478-3231.2005.01064.xopenalex-snapshot
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1478-3231.2011.02482.xopenalex-snapshot
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors
inferredcites →https://doi.org/10.1136/gut.2004.052167openalex-snapshot
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
inferredcites →https://doi.org/10.1148/radiol.10100659openalex-snapshot
Estimation of Hepatic Proton-Density Fat Fraction by Using MR Imaging at 3.0 T
inferredcites →https://doi.org/10.1148/radiol.10100708openalex-snapshot
Quantification of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat: Blinded Comparison with MR Spectroscopy
inferredcites →https://doi.org/10.1148/radiol.12120896openalex-snapshot
Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis
inferredcites →https://doi.org/10.1148/radiol.13121193openalex-snapshot
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
inferredcites →https://doi.org/10.1148/radiol.14140754openalex-snapshot
Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1148/radiol.2511080666openalex-snapshot
Nonalcoholic Fatty Liver Disease: Diagnostic and Fat-Grading Accuracy of Low-Flip-Angle Multiecho Gradient-Recalled-Echo MR Imaging at 1.5 T
inferredcites →https://doi.org/10.1161/circulationaha.105.169404openalex-snapshot
Diagnosis and Management of the Metabolic Syndrome
inferredcites →https://doi.org/10.1210/jc.2009-0541openalex-snapshot
Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients
inferredcites →https://doi.org/10.1210/jc.2014-2739openalex-snapshot
WITHDRAWN: High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels (article published in final form as 10.1210/jc.2015-1966)
inferredcites →https://doi.org/10.1210/jc.2015-1966openalex-snapshot
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
inferredcites →https://doi.org/10.1371/journal.pmed.0040296openalex-snapshot
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
inferredcites →https://doi.org/10.1503/cmaj.092144openalex-snapshot
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
inferredcites →https://doi.org/10.2337/dc06-2247openalex-snapshot
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
inferredcites →https://doi.org/10.2337/dc10-2229openalex-snapshot
Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study
inferredcites →https://doi.org/10.2337/dc11-0174openalex-snapshot
Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
inferredcites →https://doi.org/10.2337/dc12-s011openalex-snapshot
Standards of Medical Care in Diabetes—2012
inferredcites →https://doi.org/10.2337/dc13-s011openalex-snapshot
Standards of Medical Care in Diabetes—2013
inferredcites →https://doi.org/10.2337/dc14-1239openalex-snapshot
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
inferredcites →https://doi.org/10.3109/07853890.2010.518623openalex-snapshot
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4193358openalex-extracted
An Assessment of Atherosclerotic Cardiovascular Disease in Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/advs.201801585openalex-snapshot
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
inferred← citeshttps://doi.org/10.1002/hep.28337openalex-snapshot
Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy‐proven nonalcoholic fatty liver disease: A prospective study
inferred← citeshttps://doi.org/10.1002/hep.29085openalex-snapshot
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/hep.29197openalex-snapshot
How to identify patients with advanced liver disease in the community?
inferred← citeshttps://doi.org/10.1002/hep.29639openalex-snapshot
Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis
inferred← citeshttps://doi.org/10.1002/hep.30974openalex-snapshot
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.32244openalex-snapshot
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep4.1603openalex-snapshot
Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans
inferred← citeshttps://doi.org/10.1002/mrm.70057openalex-snapshot
Liver fat quantification at 0. 55 T enabled by locally low‐rank enforced deep learning reconstruction
inferred← citeshttps://doi.org/10.1002/oby.23263openalex-snapshot
Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/oby.24130openalex-snapshot
Obesity increases the risk of hepatic fibrosis in young adults with type 2 diabetes mellitus: the need to screen
inferred← citeshttps://doi.org/10.1007/978-3-030-36694-0_17openalex-snapshot
Diabetes and NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-030-40542-7_10openalex-snapshot
Fibrosis Assessment in Patients with NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-319-27316-7_17-1openalex-snapshot
Diabetes and NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-319-27316-7_17-2openalex-snapshot
Diabetes and NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-319-44433-8_17openalex-snapshot
Diabetes and NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-319-95828-6_12openalex-snapshot
Diagnostic Algorithm for the Identification of NAFLD in Primary Care
inferred← citeshttps://doi.org/10.1007/978-3-319-95828-6_8openalex-snapshot
NAFLD, Diabetes, and Other Endocrine Diseases: Clinical Implications
inferred← citeshttps://doi.org/10.1007/s00125-016-3944-1openalex-snapshot
Diagnosis of non-alcoholic fatty liver disease (NAFLD)
inferred← citeshttps://doi.org/10.1007/s00261-019-02079-zopenalex-snapshot
Measurement of spleen fat on MRI-proton density fat fraction arises from reconstruction of noise
inferred← citeshttps://doi.org/10.1007/s00261-026-05449-6openalex-snapshot
MRI-derived visceral adipose tissue quantification enhances stratification of nonalcoholic steatohepatitis severity and fibrosis in obesity
inferred← citeshttps://doi.org/10.1007/s00330-017-5075-6openalex-snapshot
Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study
inferred← citeshttps://doi.org/10.1007/s00330-021-08381-zopenalex-snapshot
MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T
inferred← citeshttps://doi.org/10.1007/s00535-017-1415-1openalex-snapshot
Current and future pharmacological therapies for NAFLD/NASH
inferred← citeshttps://doi.org/10.1007/s10620-016-4037-1openalex-snapshot
Quantitative Imaging Biomarkers of NAFLD
inferred← citeshttps://doi.org/10.1007/s10620-021-06955-xopenalex-snapshot
Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes
inferred← citeshttps://doi.org/10.1007/s10620-024-08601-8openalex-snapshot
Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis
inferred← citeshttps://doi.org/10.1007/s11428-016-0143-0openalex-snapshot
Nichtalkoholische Steatohepatitis und ihre Folgen
inferred← citeshttps://doi.org/10.1007/s11892-021-01383-7openalex-snapshot
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
inferred← citeshttps://doi.org/10.1007/s11901-019-00497-7openalex-snapshot
Should We Screen High-Risk Populations for NAFLD?
inferred← citeshttps://doi.org/10.1007/s11904-018-0392-1openalex-snapshot
NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
inferred← citeshttps://doi.org/10.1007/s11904-020-00531-0openalex-snapshot
NASH in HIV
inferred← citeshttps://doi.org/10.1007/s12020-021-02828-5openalex-snapshot
Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study
inferred← citeshttps://doi.org/10.1007/s12072-023-10625-7openalex-snapshot
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes
inferred← citeshttps://doi.org/10.1007/s12325-020-01503-xopenalex-snapshot
Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data
inferred← citeshttps://doi.org/10.1007/s42000-018-0012-xopenalex-snapshot
Imaging of nonalcoholic fatty liver disease and its clinical utility
inferred← citeshttps://doi.org/10.1016/b978-0-323-99649-5.00003-0openalex-snapshot
Clinical diagnosis and evaluation pathway
inferred← citeshttps://doi.org/10.1016/j.ahjo.2024.100457openalex-snapshot
Liver fibrosis according to diabetes status and relation to cardiovascular risk and mortality in US adults
inferred← citeshttps://doi.org/10.1016/j.amjmed.2020.08.010openalex-snapshot
The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
inferred← citeshttps://doi.org/10.1016/j.aohep.2021.100336openalex-snapshot
The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
inferred← citeshttps://doi.org/10.1016/j.aohep.2022.100774openalex-snapshot
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD
inferred← citeshttps://doi.org/10.1016/j.beem.2016.06.006openalex-snapshot
Non-alcoholic fatty liver disease and risk of type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.cgh.2017.04.045openalex-snapshot
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity
inferred← citeshttps://doi.org/10.1016/j.cgh.2019.11.060openalex-snapshot
Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging–Proton Density Fat Fraction as the Standard
inferred← citeshttps://doi.org/10.1016/j.cgh.2021.09.041openalex-snapshot
Clinical Utility of Magnetic Resonance Imaging Biomarkers for Identifying Nonalcoholic Steatohepatitis Patients at High Risk of Progression: A Multicenter Pooled Data and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.cgh.2022.10.020openalex-snapshot
Diagnostic Performance of Noninvasive Tests for Advanced Hepatic Fibrosis in Young Age Population
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.04.017openalex-snapshot
Intestinal failure-associated steatosis and fibroblast growth factor 21 plasma levels among adult chronic intestinal failure patients
inferred← citeshttps://doi.org/10.1016/j.clnesp.2025.08.016openalex-snapshot
The diagnostic value of controlled attenuation parameter (CAP) and magnetic resonance imaging derived proton density fat fraction (MRI-PDFF) for the evaluation of intestinal failure-associated liver steatosis among adult chronic intestinal failure patients
inferred← citeshttps://doi.org/10.1016/j.diabet.2018.03.002openalex-snapshot
Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes
inferred← citeshttps://doi.org/10.1016/j.diabet.2019.11.004openalex-snapshot
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.diabres.2017.10.023openalex-snapshot
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients
inferred← citeshttps://doi.org/10.1016/j.diabres.2021.108882openalex-snapshot
Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study
inferred← citeshttps://doi.org/10.1016/j.diabres.2022.109208openalex-snapshot
Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.03.010openalex-snapshot
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
inferred← citeshttps://doi.org/10.1016/j.eprac.2026.01.006openalex-snapshot
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes – 2026 Update
inferred← citeshttps://doi.org/10.1016/j.gastha.2026.101022openalex-snapshot
Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction–Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/j.gastre.2017.02.003openalex-snapshot
Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the Chilean population
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2017.02.009openalex-snapshot
Fragmento sérico de citoqueratina-18 como marcador no invasivo de esteatohepatitis no alcohólica en población chilena
inferred← citeshttps://doi.org/10.1016/j.imlet.2017.11.012openalex-snapshot
The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?
inferred← citeshttps://doi.org/10.1016/j.jdiacomp.2021.107978openalex-snapshot
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.04.021openalex-snapshot
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.jhep.2016.06.005openalex-snapshot
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
inferred← citeshttps://doi.org/10.1016/j.jhep.2017.09.021openalex-snapshot
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.11.010openalex-snapshot
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.jhepr.2021.100262openalex-snapshot
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank
inferred← citeshttps://doi.org/10.1016/j.medcle.2017.11.009openalex-snapshot
Non-alcoholic fatty liver disease: A poorly known pandemic
inferred← citeshttps://doi.org/10.1016/j.medcli.2017.06.026openalex-snapshot
Hígado graso no alcohólico: una pandemia poco conocida
inferred← citeshttps://doi.org/10.1016/j.metabol.2021.154868openalex-snapshot
Diabetes and metabolic dysfunction-associated fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.molmet.2021.101167openalex-snapshot
Imaging biomarkers of NAFLD, NASH, and fibrosis
inferred← citeshttps://doi.org/10.1016/j.obmed.2020.100243openalex-snapshot
Non Alcoholic Fatty Liver Disease and Degree of Steatosis in Diabetic and Non- Diabetic patients
inferred← citeshttps://doi.org/10.1016/j.transproceed.2019.04.062openalex-snapshot
Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients
inferred← citeshttps://doi.org/10.1016/s0016-5085(17)30587-5openalex-snapshot
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/s0168-8278(17)30769-9openalex-snapshot
Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/s1155-1976(16)71812-2openalex-snapshot
10.1016/s1155-1976(16)71812-2
inferred← citeshttps://doi.org/10.1016/s2468-1253(20)30186-2openalex-snapshot
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
inferred← citeshttps://doi.org/10.1038/nrgastro.2016.147openalex-snapshot
NAFLD and diabetes mellitus
inferred← citeshttps://doi.org/10.1038/s41575-018-0011-zopenalex-snapshot
The gut–liver axis and the intersection with the microbiome
inferred← citeshttps://doi.org/10.1038/s41575-018-0031-8openalex-snapshot
Publisher Correction: The gut–liver axis and the intersection with the microbiome
inferred← citeshttps://doi.org/10.1038/s41588-022-01199-5openalex-snapshot
Multiomics study of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1038/s41598-025-03528-0openalex-snapshot
Nonlinear relationship between serum high sensitivity C reactive protein to high density lipoprotein cholesterol ratio with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2016.03.005openalex-snapshot
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
inferred← citeshttps://doi.org/10.1053/j.gastro.2016.10.026openalex-snapshot
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.04.014openalex-snapshot
Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2018.12.036openalex-snapshot
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2021.07.049openalex-snapshot
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1055/a-2082-5203openalex-snapshot
Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting
inferred← citeshttps://doi.org/10.1055/s-0042-1742574openalex-snapshot
Fatty Liver Disease: Pathophysiology and Imaging Features
inferred← citeshttps://doi.org/10.1080/08998280.2018.1543227openalex-snapshot
Testing the ability of the nonalcoholic fatty liver disease fibrosis score to predict 1-year all-cause hospital admission
inferred← citeshttps://doi.org/10.1080/17474124.2019.1649981openalex-snapshot
Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations
inferred← citeshttps://doi.org/10.1080/17474124.2023.2165489openalex-snapshot
The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis
inferred← citeshttps://doi.org/10.1080/17512433.2017.1299573openalex-snapshot
Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)
inferred← citeshttps://doi.org/10.1089/met.2021.0098openalex-snapshot
PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1093/cid/ciaa429openalex-snapshot
Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard
inferred← citeshttps://doi.org/10.1093/ndt/gfab266openalex-snapshot
Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study
inferred← citeshttps://doi.org/10.1097/hep.0000000000000323openalex-snapshot
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/hep.0000000000000635openalex-snapshot
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1097/mcg.0000000000001780openalex-snapshot
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1097/md.0000000000007778openalex-snapshot
Estimating of hepatic fat amount using MRI proton density fat fraction in a real practice setting
inferred← citeshttps://doi.org/10.1097/md.0000000000024940openalex-snapshot
Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1097/md.0000000000038340openalex-snapshot
Lipoprotein(a) level predicts the development of nonalcoholic fatty liver disease in Korean adults: A retrospective longitudinal study
inferred← citeshttps://doi.org/10.1097/meg.0000000000000681openalex-snapshot
Prevalence of hepatic steatosis in apparently healthy medical students: a transient elastography study on the basis of a controlled attenuation parameter
inferred← citeshttps://doi.org/10.1097/meg.0000000000001304openalex-snapshot
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
inferred← citeshttps://doi.org/10.1111/apt.13421openalex-snapshot
Editorial: screening for NAFLD – a promising strategy to mitigate future burden of liver disease
inferred← citeshttps://doi.org/10.1111/apt.14327openalex-snapshot
Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination Survey
inferred← citeshttps://doi.org/10.1111/apt.14463openalex-snapshot
Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross‐sectional study using transient elastography
inferred← citeshttps://doi.org/10.1111/apt.14554openalex-snapshot
Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct‐acting anti‐viral therapy
inferred← citeshttps://doi.org/10.1111/apt.14976openalex-snapshot
Predictors of advanced fibrosis in non‐cirrhotic non‐alcoholic fatty liver disease in Germany
inferred← citeshttps://doi.org/10.1111/apt.15626openalex-snapshot
Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check‐up clinic population
inferred← citeshttps://doi.org/10.1111/apt.16324openalex-snapshot
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/apt.16350openalex-snapshot
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non‐alcoholic fatty liver disease—simply associated or more complicated?
inferred← citeshttps://doi.org/10.1111/apt.16392openalex-snapshot
The impact of genetic risk on liver fibrosis in non‐alcoholic fatty liver disease as assessed by magnetic resonance elastography
inferred← citeshttps://doi.org/10.1111/apt.17637openalex-snapshot
Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes
inferred← citeshttps://doi.org/10.1111/apt.17997openalex-snapshot
A prospective study on the prevalence of at‐risk MASH in patients with type 2 diabetes mellitus in the United States
inferred← citeshttps://doi.org/10.1111/apt.18377openalex-snapshot
A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia
inferred← citeshttps://doi.org/10.1111/dme.13540openalex-snapshot
Prevalence and severity of non‐alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital
inferred← citeshttps://doi.org/10.1111/dme.14356openalex-snapshot
Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.12973openalex-snapshot
Non‐alcoholic fatty liver disease ( NAFLD ) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
inferred← citeshttps://doi.org/10.1111/dom.14651openalex-snapshot
The metabolic triad of non‐alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment
inferred← citeshttps://doi.org/10.1111/liv.13481openalex-snapshot
Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan
inferred← citeshttps://doi.org/10.1111/liv.13739openalex-snapshot
Diabetes impacts prediction of cirrhosis and prognosis by non‐invasive fibrosis models in non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/liv.13993openalex-snapshot
Longitudinal analysis of risk of non‐alcoholic fatty liver disease in adulthood
inferred← citeshttps://doi.org/10.1111/liv.14255openalex-snapshot
Abstracts
inferred← citeshttps://doi.org/10.1111/liv.15171openalex-snapshot
The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population‐based follow‐up study ( NASHCO )
inferred← citeshttps://doi.org/10.1111/liv.15259openalex-snapshot
Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
inferred← citeshttps://doi.org/10.1124/dmd.121.000413openalex-snapshot
Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations
inferred← citeshttps://doi.org/10.1136/gutjnl-2019-319104openalex-snapshot
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
inferred← citeshttps://doi.org/10.1136/gutjnl-2023-330110openalex-snapshot
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1136/jim-2017-000609openalex-snapshot
Cytokeratin-18 and Enhanced Liver Fibrosis Scores in Type 1 and Type 2 Diabetes and Effects of Two Different Insulins
inferred← citeshttps://doi.org/10.1142/s012906572050032xopenalex-snapshot
Automated MRI-Based Deep Learning Model for Detection of Alzheimer’s Disease Process
inferred← citeshttps://doi.org/10.1155/2019/2013674openalex-snapshot
Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?
inferred← citeshttps://doi.org/10.1155/2021/3642463openalex-snapshot
Protective Effects of Iridoid Glycoside from Corni Fructus on Type 2 Diabetes with Nonalcoholic Fatty Liver in Mice
inferred← citeshttps://doi.org/10.1155/2022/2760027openalex-snapshot
Fibrosis‐4 Index Is Closely Associated with Arterial Damage and Future Risk of Coronary Heart Disease in Type 2 Diabetes
inferred← citeshttps://doi.org/10.1158/1940-6207.capr-15-0406openalex-snapshot
Transforming Cancer Prevention through Precision Medicine and Immune-oncology
inferred← citeshttps://doi.org/10.1159/000448940openalex-snapshot
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome
inferred← citeshttps://doi.org/10.1159/000531574openalex-snapshot
Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1172/jci.insight.95354openalex-snapshot
Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis
inferred← citeshttps://doi.org/10.1177/1756283x16656735openalex-snapshot
Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1177/17562848221093869openalex-snapshot
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1186/s12876-021-01763-zopenalex-snapshot
Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
inferred← citeshttps://doi.org/10.1186/s43055-024-01322-yopenalex-snapshot
Quantification of liver fat using non-invasive MRI-PDFF technique versus guided biopsy in potential liver donor
inferred← citeshttps://doi.org/10.1371/journal.pone.0147237openalex-snapshot
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score
inferred← citeshttps://doi.org/10.1371/journal.pone.0203054openalex-snapshot
Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial
inferred← citeshttps://doi.org/10.1371/journal.pone.0269070openalex-snapshot
Risk of liver fibrosis in patients with prediabetes and diabetes mellitus
inferred← citeshttps://doi.org/10.14341/dm9372openalex-snapshot
Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
inferred← citeshttps://doi.org/10.14739/2310-1210.2020.1.194497openalex-snapshot
Non-invasive fibrosis markers and elastography in diagnosis of fibrosis severity in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.14740/gr1074wopenalex-snapshot
Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients
inferred← citeshttps://doi.org/10.15393/j6.art.2016.3542openalex-snapshot
Clinical features of nonalcoholic fatty liver disease assoсiated with type 2 diabetes
inferred← citeshttps://doi.org/10.17116/terarkh201789259-65openalex-snapshot
Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
inferred← citeshttps://doi.org/10.18203/2349-3933.ijam20221093openalex-snapshot
A study of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus and its correlation with cardiovascular risk
inferred← citeshttps://doi.org/10.18705/2311-4495-2023-10-2-146-153openalex-snapshot
NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: MODERN IMAGING MODALITIES
inferred← citeshttps://doi.org/10.20517/2394-5079.2020.75openalex-snapshot
Prevalence and incidence of intra- and extrahepatic complications of NAFLD in patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.21037/apm-21-1176openalex-snapshot
Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.21037/atm-20-5216openalex-snapshot
Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes
inferred← citeshttps://doi.org/10.21037/hbsn-23-563openalex-snapshot
Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4118620/v1openalex-snapshot
Association of TM6SF2 (E167K) with NAFLD in adult Greek people with Type 2 Diabetes Mellitus (T2DM)
inferred← citeshttps://doi.org/10.2147/ijgm.s460200openalex-snapshot
Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
inferred← citeshttps://doi.org/10.2152/jmi.67.280openalex-snapshot
Long-term empagliflozin therapy improves levels of hepatic fibrosis marker in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.21608/bfsa.2023.301124openalex-snapshot
ASSESSMENT OF PENTOXIFYLLINE EFFECTS ON LIVER STEATOSIS UTILIZING DIXON-BASED MRI TECHNIQUE; RANDOMIZED CONTROLLED STUDY
inferred← citeshttps://doi.org/10.2174/1573402116999201209203534openalex-snapshot
Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
inferred← citeshttps://doi.org/10.2337/cd21-0104openalex-snapshot
Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes
inferred← citeshttps://doi.org/10.2337/dc16-1787openalex-snapshot
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
inferred← citeshttps://doi.org/10.2337/dc20-1778openalex-snapshot
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
inferred← citeshttps://doi.org/10.2337/dc20-1997openalex-snapshot
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
inferred← citeshttps://doi.org/10.25148/etd.fidc009566openalex-snapshot
Food Insecurity is Associated with Nonalcoholic Fatty Liver Disease, Cognitive Impairment, and Immune Activation in People Living with HIV
inferred← citeshttps://doi.org/10.26442/00403660.2019.12.000134openalex-snapshot
Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development
inferred← citeshttps://doi.org/10.26442/00403660.2022.02.201363openalex-snapshot
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
inferred← citeshttps://doi.org/10.26481/dis.20190704skopenalex-snapshot
Gastrointestinal manifestations in patients with diabetes mellitus
inferred← citeshttps://doi.org/10.26693/jmbs03.05.110openalex-snapshot
Endogenous Intoxication Syndrome in Patients with Diabetes Mellitus in Combination with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.30682/ildia2102aopenalex-snapshot
Epidemiologia e storia naturale della NAFLD, una malattia sistemica
inferred← citeshttps://doi.org/10.31031/iod.2020.03.000570openalex-snapshot
Estimated Prevalence of Advanced Hepatic Fibrosis by Elastography in Patients with Type 2 Diabetes
inferred← citeshttps://doi.org/10.3350/cmh.2022.0336openalex-snapshot
Screening strategy for non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3389/fcvm.2022.991383openalex-snapshot
Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches
inferred← citeshttps://doi.org/10.3389/fendo.2025.1643842openalex-snapshot
Association of UHR and ECG parameters with type 2 diabetes mellitus in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3389/fphar.2019.00877openalex-snapshot
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
inferred← citeshttps://doi.org/10.3390/biomedicines10102530openalex-snapshot
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives
inferred← citeshttps://doi.org/10.3390/diagnostics10100809openalex-snapshot
Clinical and Biochemical Predictors of Nonalcoholic Fatty Liver Disease among Type 2 Diabetes Mellitus Patients at Primary Health Care Level in South Western Saudi Arabia
inferred← citeshttps://doi.org/10.3390/diagnostics11122341openalex-snapshot
The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
inferred← citeshttps://doi.org/10.3390/diagnostics14222500openalex-snapshot
Modified FIB-4 Index in Type 2 Diabetes Mellitus with Steatosis: A Non-Linear Predictive Model for Advanced Hepatic Fibrosis
inferred← citeshttps://doi.org/10.3390/healthcare12050591openalex-snapshot
Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study
inferred← citeshttps://doi.org/10.3390/ijms21113863openalex-snapshot
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms222011128openalex-snapshot
The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm10245755openalex-snapshot
Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care
inferred← citeshttps://doi.org/10.3390/nu9060634openalex-snapshot
Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
inferred← citeshttps://doi.org/10.3410/f.727023474.793574478openalex-snapshot
Faculty Opinions recommendation of Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis.
inferred← citeshttps://doi.org/10.34172/aim.2021.28openalex-snapshot
Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening
inferred← citeshttps://doi.org/10.37352/2020432.2openalex-snapshot
Manejo de la enfermedad hepática metabólica grasa
inferred← citeshttps://doi.org/10.3748/wjg.v25.i11.1307openalex-snapshot
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
inferred← citeshttps://doi.org/10.3748/wjg.v27.i19.2281openalex-snapshot
Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease
inferred← citeshttps://doi.org/10.3945/jn.116.240358openalex-snapshot
Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens
inferred← citeshttps://doi.org/10.4093/dmj.2020.0118openalex-snapshot
Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.4093/dmj.2022.0381openalex-snapshot
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
inferred← citeshttps://doi.org/10.4093/jkd.2017.18.2.88openalex-snapshot
Radiologic Evaluation of Non-Alcoholic Fatty Liver Disease in Diabetic Patient
inferred← citeshttps://doi.org/10.4137/cmt.s18885openalex-snapshot
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options
inferred← citeshttps://doi.org/10.5604/16652681.1212434openalex-snapshot
High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.
inferred← citeshttps://doi.org/10.5772/intechopen.72668openalex-snapshot
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.6084/m9.figshare.14457104openalex-snapshot
Additional file 1 of Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
inferred← citeshttps://doi.org/10.63096/medtigo30622466openalex-snapshot
A Literature Review on Fatty Liver Disease
inferred← citeshttps://doi.org/10.70675/215a8b02zdac2z4a71z802bz1c60de192f4dopenalex-snapshot
Performances pronostiques du FibroTest chez les sujets avec maladie métabolique du foie
inferred← citeshttps://doi.org/10.70675/d03174c8z45cez439ezba77z41b6ed9403b3openalex-snapshot
Étude de deux acteurs dans le développement des complications hépatiques liées à l’obésité : la vitamine D et FNDC5/Irisine
showing the first 200 of 206 · page through all 206
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.